Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

NYSE:DNA   1:16:15 PM EDT
12.06
+0.06 (+0.50%)
Earnings Announcements

Ginkgo Bioworks Reports Third Quarter 2021 Results

Published: 11/15/2021 13:18 GMT
Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A (DNA) - Ginkgo Bioworks Reports Third Quarter 2021 Results.
Q3 Revenue $77.6 Million Versus $13.3 Million.
Qtrly Loss per Share $0.08.
Sees Total Foundry Revenue of at Least $100 Million for FY21, Inclusive of Downstream Value Share and Services Revenue.
Revenue is expected to be $55.25 Million
Adjusted EPS is expected to be -$0.03

Next Quarter Revenue Guidance is expected to be $59.8 Million
Next Quarter EPS Guidance is expected to be -$0.03

More details on our Analysts Page.